WEISS MICHAEL S 4

What Happened

• Michael S. Weiss, Executive Vice Chairman and Director of Fortress Biotech (FBIO), was granted 475,424 restricted shares on March 18, 2026. The Form 4 reports the acquisition as an award (transaction code A) at a reported price of $0.00 (i.e., a grant), with a reported dollar amount of $0. The grant was made pursuant to the issuer's Long-Term Incentive Plan.

Key Details

• Transaction date: 2026-03-18; Filing date: 2026-03-20 (filed within the 2-business-day Form 4 window).
• Transaction type/code: Award/Grant (A).
• Shares granted: 475,424 restricted common shares; reported acquisition price: $0.00.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote: Grant was made under the issuer’s Long-Term Incentive Plan (LTIP).
• No sale, open-market purchase, option exercise, 10b5-1 plan or tax-withholding event reported in this filing.

Context

• Restricted share awards are typically subject to vesting and other conditions set by the LTIP; they represent compensation/retention incentives rather than an outright market purchase or sale. Such grants don't necessarily indicate immediate buying pressure or a short-term sentiment shift by the insider.